http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0187893-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6f989dae191cbd547826460bf91c62d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc757f0c7c44b006bfa0e7c1e86bb793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb78d1d2975267ea4a52b862745f430
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
filingDate 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7104f81f073949b1145ca84b2f83e6e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cf582a7e215743ca6fd86866192b2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e106291e497a644d0a5022c45871bbd
publicationDate 2001-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0187893-A1
titleOfInvention Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
abstract There is described a process for the preparation of a pure and pharmacopoeial amorphous form of cefuroxime axetil which involves dissolving crystalline cefuroxime axetil in acetic acid and recovering amorphous form of cefuroxime axetil from the solution by the addition of water, the water being dumped and in a volume which is at least 25 times the weight of the crystalline cefuroxime axetil.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1373276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1619198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006026531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1373276-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7045618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7393952-B2
priorityDate 2000-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4775750-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5847118-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128267996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136251628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57280286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226710517

Total number of triples: 51.